SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-101221
Filing Date
2016-05-12
Accepted
2016-05-12 15:29:18
Documents
48
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v439095_10q.htm 10-Q 535114
2 EXHIBIT 10.1 v439095_ex10-1.htm EX-10.1 11762
3 EXHIBIT 31.1 v439095_ex31-1.htm EX-31.1 9822
4 EXHIBIT 31.2 v439095_ex31-2.htm EX-31.2 9867
5 EXHIBIT 32.1 v439095_ex32-1.htm EX-32.1 4595
6 EXHIBIT 32.2 v439095_ex32-2.htm EX-32.2 4832
  Complete submission text file 0001144204-16-101221.txt   2559715

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT svon-20160331.xml EX-101.INS 369358
8 XBRL TAXONOMY EXTENSION SCHEMA svon-20160331.xsd EX-101.SCH 27246
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE svon-20160331_cal.xml EX-101.CAL 30432
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE svon-20160331_def.xml EX-101.DEF 174998
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE svon-20160331_lab.xml EX-101.LAB 240265
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svon-20160331_pre.xml EX-101.PRE 200292
Mailing Address 4045 SORRENTO VALLEY BOULEVARD SAN DIEGO CA 92121
Business Address 4045 SORRENTO VALLEY BOULEVARD SAN DIEGO CA 92121 908-864-4444
Sevion Therapeutics, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 161643457
SIC: 8731 Services-Commercial Physical & Biological Research